Search results for "MARA"

showing 10 items of 343 documents

Fluticasone propionate/formoterol: a fixed-combination therapy with flexible dosage.

2014

International guidelines describe asthma control as the main outcome of asthma management. Prevention of symptoms, improved quality of life, and reduction of exacerbations are the main components, consequently decreasing health care costs. However, many of these objectives remain unmet in real life: several surveys show that a large proportion of asthmatic patients are not well controlled despite the efficacy of current available treatment. Several randomized controlled clinical trials indicate that combining inhaled corticosteroids and long-acting β2-agonists, by means of a single inhaler, greatly improves the management of the disease. The results of 9 multicenter phase III clinical studi…

medicine.medical_specialtyCombination therapyAsthma exacerbationSettore MED/10 - Malattie dell'Apparato RespiratorioSettore MED/10 - Malattie Dell'Apparato RespiratorioFluticasone propionateAsthma control; Asthma exacerbations; Fixed-combination therapy; Fluticasone propionate/formoterol; Single-aerosol inhalerAsthma controlFluticasone propionate/formoterolForced Expiratory VolumeFormoterol FumarateInternal MedicineMedicineHumansAnti-Asthmatic AgentsAsthma exacerbationsParticle SizeIntensive care medicineAsthmaFluticasonebusiness.industryInhalerNebulizers and VaporizersFixed-combination therapyAsthma control; Asthma exacerbations; Fixed-combination therapy; Fluticasone propionate/formoterol; Single-aerosol inhaler; Androstadienes; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Drug Combinations; Ethanolamines; Fluticasone; Forced Expiratory Volume; Formoterol Fumarate; Humans; Nebulizers and Vaporizers; Particle Size; Quality of Life; Treatment Outcomemedicine.diseaseSingle-aerosol inhalerAsthmaBronchodilator AgentsAndrostadienesDrug CombinationsTreatment OutcomeTolerabilityAsthma control Asthma exacerbations Fixed-combination therapy Fluticasone propionate/formoterol Single-aerosol inhalerEthanolaminesAnesthesiaAsthma exacerbations; Asthma control; Fixed-combination therapy; Fluticasone propionate/formoterol; Single-aerosol inhalerQuality of LifeFluticasoneFormoterol FumarateFormoterolbusinessmedicine.drugEuropean journal of internal medicine
researchProduct

Effect of marathon characteristics and runners' time category on pacing profile.

2020

This study aimed to analyse differences in pacing profiles in four marathon competitions and to explore that pacing per time category. A database of 91,493 runners gathered from 4 different races was analysed (Valencia, Chicago, London and Tokyo Marathon). Participants were categorized in accordance with their completion time. The relative speed of each section for each runner was calculated as a percentage of the average speed for the entire race. In the four marathons studied, the first 5 km differed widely, presenting London the highest relative speeds (5 km: CI95% London vs. Valencia [12.1, 13.6%],

medicine.medical_specialtyCompetitive BehaviorTime Factors030209 endocrinology & metabolismPhysical Therapy Sports Therapy and RehabilitationMarathon Running030229 sport sciencesGeneral MedicineAthletic Performance03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationmedicinePhysical EnduranceHumansOrthopedics and Sports MedicinePsychologyEuropean journal of sport science
researchProduct

Antiplatelet Therapy in Marathon Runners: More Harm than Benefits?

2013

We read with interest the article by Arthur J. Siegel, who recently concluded that prophylactic aspirin for primary prevention of cardiac events in marathon runners may be a viable approach for lowering the global risk of cardiovascular events in these subjects. Although there is a credible hysiological basis for supporting this provocative suggesion, and the use of nonsteroidal anti-inflammatory drugs is requent in athletes, there are, however, some issues that hould be considered, and which would globally overwhelm he hypothetical advantages of antiplatelet therapy in this eculiar setting. First, there is no controlled, randomized study that has efinitely proven the existence of any poten…

medicine.medical_specialtyMarathon runningantiplatelet therapylaw.inventionchemistry.chemical_compoundRandomized controlled triallawantiplatelet therapy; marathon race; harmAntithromboticmedicineAspirinNonsteroidalbiologyAthletesbusiness.industryGeneral Medicinebiology.organism_classificationmarathon raceHarmchemistryPhysical therapyAcute thrombosisbusinesshuman activitiesharmmedicine.drugThe American Journal of Medicine
researchProduct

Inter-individual different responses to continuous and interval training in recreational middle-aged women runners

2020

A crucial subject in sports is identifying the inter-individual variation in response to training, which would allow creating individualized pre-training schedules, improving runner’s performance. We aimed to analyze heterogeneity in individual responses to two half-marathon training programs differing in running volume and intensity in middle-aged recreational women. 20 women (40 ± 7 years, 61 ± 7 kg, 167 ± 6 cm, and VO2max = 48 ± 6 mL⋅kg–1⋅min–1) underwent either moderate-intensity continuous (MICT) or high-intensity interval (HIIT) 12-week training. They were evaluated before and after training with maximal incremental tests in the laboratory (VO2max) and in the field (time to exhaustion…

medicine.medical_specialtyPhysiologyRunners (Sports)responderhigh intensity interval trainingexercise and sportPhysical education and traininglcsh:PhysiologyInterval trainingmiddle-aged women03 medical and health sciences0302 clinical medicinePhysiology (medical)Dones esportistesMedicine030212 general & internal medicineTime to exhaustionlcsh:QP1-981business.industryWomen athletes030229 sport sciencesBrief Research ReportHIIT-High-intensity interval trainingShort intervalmoderate intense endurance exercise trainingCorredors (Esports)non-responderHomogeneoushalf-marathon runnersPhysical therapyEducació físicabusinessHigh-intensity interval training
researchProduct

Stress and recovery states after a 24 h ultra-marathon race: A one-month follow-up study

2011

Abstract Objectives The purpose of this study was to investigate the athlete’s perception of stress and recovery states following a 24 h ultra-marathon race. Design and method Psychological states were assessed in 14 male subjects before as well as 1, 3, 6, 9, 12, 15, 21, and 30 days after the race. Results The results suggest an ultra-endurance race induces perceived stress and leads to subsequent alterations in perceived recovery, whatever the psychological, physical, emotional or social dimensions according to a unique time-course for the several components evaluating the stress and recovery process. Stress and recovery levels related to the 24 h race showed that a period of 2 weeks is r…

medicine.medical_specialtybiologyAthletesTotal recoverybiology.organism_classificationSocial dimensionUltra marathonRace (biology)Stress processPhysical medicine and rehabilitationStress (linguistics)medicinePsychologyApplied PsychologyClinical psychologyMonth follow upPsychology of Sport and Exercise
researchProduct

Acute hepatotoxicity induced by quetiapine fumarate in larval zebrafish

2016

medicine.medical_specialtybusiness.industryPharmacology030227 psychiatry03 medical and health sciences0302 clinical medicineEndocrinologymedicine.anatomical_structureInternal medicineQuetiapine FumarateZebrafish larvaemedicine030211 gastroenterology & hepatologyYolk sacbusinessFundamental Toxicological Sciences
researchProduct

Anterior chamber depth measurement in teenagers. Comparison of two techniques

2013

Purpose: The aim of this study is to determine the anterior chamber depth (ACD) in teenagers using two different devices: partial coherence interferometry IOLMaster (Carl Zeiss Meditec) and anterior segment optical coherence tomography (Visante TM OCT, Carl Zeiss Meditec) and to evaluate the degree of agreement between ACD measurements carried out by both instruments. Methods: In this prospective study 68 eyes of 34 emmetropic Caucasic patients (18 girls and 16 boys) were analysed. ACD was measured from the anterior corneal surface to anterior surface of the crystalline lens. For each age the ACD size was calculated and the difference between IOLMaster and Visante-OCT measurements was analy…

medicine.medical_specialtygenetic structuresmedicine.medical_treatmentEmmetropiaIntraocular lensAnterior surfaceTeenagerslcsh:OphthalmologyOptical coherence tomographyOphthalmologymedicinelcsh:QC350-467Cámara anteriorCorneal surfaceAdolescentesAnterior chamberEmmetropic Caucasic patientsmedicine.diagnostic_testbusiness.industryPacientes caucásicos emetrópicoseye diseasesPruebas diagnósticas/investigaciónlcsh:RE1-994Partial coherence interferometryMeasured depthOptometryOriginal Articlesense organsDiagnostic tests/investigationbusinesslcsh:Optics. LightOptometryJournal of Optometry
researchProduct

New developments in optimizing bronchodilator treatment of COPD: a focus on glycopyrrolate/formoterol combination formulated by co-suspension deliver…

2018

COPD causes considerable health and economic burden worldwide, with incidence of the disease expected to continue to rise. Inhaled bronchodilators, such as long-acting muscarinic antagonists (LAMAs) and long-acting β2-agonists (LABAs), are central to the maintenance treatment of patients with COPD. Clinical studies have demonstrated that combined LAMA + LABA therapies improve efficacy while retaining a safety profile similar to LAMA or LABA alone. This has led to the development of several LAMA/LABA fixed-dose combination (FDC) therapies, which provide patients with the convenience of two active compounds in a single inhaler. GFF MDI (Bevespi Aerosphere®) is an FDC of glycopyrrolate/formote…

medicine.medical_specialtymedicine.drug_classDrug CompoundingFixed-dose combinationMuscarinic AntagonistsPulmonary Disease Chronic Obstructive03 medical and health sciences0302 clinical medicineFormoterol FumarateBronchodilatorAdministration InhalationmedicineHumans030212 general & internal medicineIntensive care medicineAdrenergic beta-2 Receptor AgonistsGlycopyrrolateCOPDbiologybusiness.industryInhalerGeneral MedicineLamamedicine.diseasebiology.organism_classificationGlycopyrrolateMetered-dose inhalerBronchodilator AgentsDrug CombinationsTreatment Outcome030228 respiratory systemFormoterolbusinesshormones hormone substitutes and hormone antagonistsmedicine.drugInternational Journal of Chronic Obstructive Pulmonary Disease
researchProduct

Airway Deposition of Extrafine Inhaled Triple Therapy in Patients with COPD: A Model Approach Based on Functional Respiratory Imaging Computer Simula…

2020

Omar S Usmani,1 Nicola Scichilone,2 Benjamin Mignot,3 Dennis Belmans,3 Cedric Van Holsbeke,3 Jan De Backer,3 Roberta De Maria,4 Erika Cuoghi,4 Eva Topole,4 George Georges4 1Airway Disease Section, National Heart and Lung Institute, Imperial College, London, UK; 2PROMISE Department of Medicine, University of Palermo, Palermo, Italy; 3FLUIDDA, Kontich, Belgium; 4Chiesi Farmaceutici, SpA, Parma, ItalyCorrespondence: George GeorgesChiesi USA Inc., 175 Regency Woods Place, Ste. 600, Cary, NC 27518, USATel +1 (919) 678 6611 x1536Email george.georges@chiesi.comIntroduction: There is a clear correlation between small airways dysfunction and poor clinical outcomes in patients with chronic obstructiv…

medicine.medical_specialtymedicine.drug_classRespiratory SystemUrologyInternational Journal of Chronic Obstructive Pulmonary DiseaseSettore MED/10 - Malattie Dell'Apparato RespiratoriotomographyDry powder inhalers Inhaled corticosteroid Long-acting beta2 agonist Long-acting muscarinic antagonist Metered dose inhalers Tomography X-ray computedinhaled corticosteroidFluticasone propionatePulmonary Disease Chronic Obstructivechemistry.chemical_compoundFormoterol FumarateBronchodilatorAdministration InhalationmedicineHumanslong-acting muscarinic antagonistComputer SimulationGlycopyrronium bromideRespiratory systemmetered dose inhalers1102 Cardiorespiratory Medicine and HaematologyOriginal Researchx-ray computedlcsh:RC705-779COPDScience & TechnologyInhalationbusiness.industrydry powder inhalersGeneral Medicinelcsh:Diseases of the respiratory systemrespiratory systemmedicine.diseaseBronchodilator AgentsDrug CombinationschemistryCorticosteroidVilanterolbusinessLife Sciences & Biomedicinelong-acting beta2 agonistmedicine.drugInternational Journal of COPD
researchProduct

Recovery of Inflammation, Cardiac, and Muscle Damage Biomarkers After Running a Marathon

2019

Bernat-Adell, MD, Collado-Boira, EJ, Moles-Julio, P, Panizo-González, N, Martínez-Navarro, I, Hernando-Fuster, B, and Hernando-Domingo, C. Recovery of inflammation, cardiac and muscle damage biomarkers after running a marathon. J Strength Cond Res 35(3): 626-632, 2021-Physical endurance sports conditions the increase of blood biomarkers responsible for the acute inflammatory response. The purpose of this study was to observe the impact of intense physical exercise on these biomarkers and detect their recovery pattern. This is an experimental study of repeated measures (pre-post marathon). The biomarkers lactate dehydrogenase (LDH), creatine kinase (CK), high-sensitivity troponin T (hs-TNT),…

medicine.medical_specialtyphysical activityMarathon RunningPhysical Therapy Sports Therapy and RehabilitationInflammationPhysical exercise030204 cardiovascular system & hematology03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicineLactate dehydrogenaseenergy expendituremedicineHumansOrthopedics and Sports MedicineCreatine KinaseInflammationTroponin Tbiologybusiness.industryMusclesRepeated measures design030229 sport sciencesGeneral MedicineEndocrinologyEnergy expenditurechemistryPhysical Endurancebiology.proteinBiomarker (medicine)Creatine kinasemedicine.symptombusinessBiomarkers
researchProduct